Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from Indoco Remedies Limited ( (IN:INDOCO) ).
Indoco Remedies Limited has announced that it will host an earnings conference call to discuss its unaudited financial results for the quarter and nine months ended 31 December 2025. The call, organized in association with Nirmal Bang Institutional Equities, is scheduled for Tuesday, 3 February 2026 at 3:30 p.m. IST and will feature key members of the company’s top management, including the managing director, joint managing director and chief financial officer, underscoring the importance of the interaction for investors and analysts seeking clarity on Indoco’s financial performance and business outlook.
More about Indoco Remedies Limited
Indoco Remedies Limited is an India-based pharmaceutical company engaged in the development, manufacturing and marketing of branded formulations and generics for domestic and international markets, serving both regulated and emerging geographies through prescription medicines and over-the-counter products.
Average Trading Volume: 1,761
Technical Sentiment Signal: Sell
Current Market Cap: 20.17B INR
Find detailed analytics on INDOCO stock on TipRanks’ Stock Analysis page.